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Clinical course of a malignant peripheral nerve sheath tumor in a Siberian tiger
(Panthera tigris altaica)
Hanspeter W. Steinmetz,1 Maja Ru¨tten, Katja Ruess-Melzer, Stefanie Ohlerth, Christoph Lischer,
Anna Oevermann, Beata Bode-Lesniewska, Jean-Michel Hatt
Abstract. A 14-year-old male Siberian tiger (Panthera tigris altaica) was admitted with an ulcerating mass
on the right thoracic wall. Radiographic and computed tomographic evaluation indicated 2 isolated cutaneous
masses without any signs of metastasis. Histology of a Tru-Cut biopsy revealed an anaplastic sarcoma with
giant cells. Both tumors were resected with appropriate normal tissue margins. The size of the defect did not
allow primary closure of the wound; therefore, a mesh expansion technique was attempted. Three months
later, the tiger had to be euthanized due to extensive metastasis to the lungs. Histomorphological features and
immunohistochemical results confirmed the diagnosis of malignant peripheral nerve sheath tumor. In contrast
to domestic animal experience, the tumor had spread extensively to the lungs without local reccurrence in a
short period of time. Correct diagnosis requires various immunohistochemical evaluations of the tumor tissue.
Key words: Computed tomography; immunohistochemistry; peripheral nerve sheath tumor; tigers.
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A 14-year-old male Siberian tiger (Panthera tigris altaica)
was presented to the Clinic for Zoo Animals, Exotic Pets
and Wildlife at the University of Zu¨rich (Zu¨rich, Switzer-
land) because of an ulcerating mass on the right thoracic
wall. After initial immunization for Feline panleukopenia
virus, Felid herpesvirus 1, and Feline calicivirus, the tiger
received irregular booster vaccinations 1–4 years apart until
the age of 9 years. Otherwise, he was in good health, bright
and alert, and in good body condition. Body weight was
estimated to be 200 kg. For further diagnostic evaluation,
anesthesia was induced with 0.05 mg/kg medetomidine
hydrochloridea and 2.18 mg/kg ketamine hydrochlorideb
intramuscularly. The tiger was intubated (internal diame-
ter: 14 mm),c and anesthesia was maintained by adminis-
tration of isofluraned in oxygen (end-tidal isoflurane
concentration: 1.1–1.3%). Physical examination was unre-
markable except for dental tartar, gingivitis, a missing
upper left canine tooth, and 2 ulcerating cutaneous masses
extending into the subcutis on the right thoracic wall. The
masses were well circumscribed, moveable, and spongy in
consistency (Fig. 1).
Blood was drawn for hematology and serum biochem-
istry, all of which were within reference intervals. Right and
left lateral radiographs of the thorax revealed a minor
generalized bronchointerstitial infiltrate, but no signs of
tumor metastases were seen. For the computed tomogra-
phy (CT) study, the tiger was positioned in left lateral
recumbency and scanned with a third-generation CT
scanner.e Subsequent to the scout image, 5-mm contiguous
transverse images, starting at the level of the ascending
aorta to the level of the mid-abdomen, were obtained
before and after intravenous bolus injection of a nonionic,
iodinated contrast mediumf (600 mg iodine/kg body
weight). All images were acquired at 130 kVp and 100 mA
with a field of view of 450 mm using a soft-tissue algorithm.
The CT examination identified 2 cutaneous soft-tissue
masses extending into the subcutis of the right side of the
body. The larger mass was dorsal to the 12th and 13th rib
and measured 6 cm 3 19 cm 3 15 cm. The larger mass had
an irregular surface, and the dorsal, cranial, and caudal
margins were ill defined with fusiform subcutaneous
extensions approximately 2 cm long. The smaller mass
was 15 cm ventral to the larger mass and located at the level
of the 13th rib cartilage. The smaller mass measured 2 cm 3
5 cm 3 6 cm. This smaller mass was oval and well defined.
Dorsally, a fusiform subcutaneous extension of the mass
was noted. Neither mass involved deeper structures, and
contrast enhancement was not noted. The lung parenchyma
and the thoracic lymph nodes were unremarkable (Fig. 2).
After the CT examination, the tiger underwent surgery in
left lateral recumbency. A constant rate infusion of
fentanylg (500 mg/h) was administered during surgery to
provide additional pain relief. An elliptical incision parallel
to the skin lines was created including both masses. With
continuous dissection of the subcutaneous tissue, the
tumors could be easily mobilized and resected. With the
help of CT images, 3 cm of grossly normal tissue was
excised around the masses in all planes. The size of the
defect did not allow primary closure of the wound;
therefore, a mesh expansion technique was attempted.
Several stab incisions in the cutis allowed the stretching of
the cutis to adapt wound edges for primary healing (Fig. 3).
Wound closure was achieved in 2 layers, continuous
subcutaneous and a continuous intradermal pattern.
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Polyglactin 910h (USB 1) sutures were used. No wound
dressing was applied. At the end of surgery, buprenorphinei
was administered (0.018 mg/kg, intravenously) for pain
relief, and the medetomidine hydrochloride was reversed
with atipamezole hydrochloride.j Postoperative treatment
included amoxicillink (10 mg/kg twice a day) and melox-
icaml (0.05 mg/kg once a day) orally for 10 days.
Tissue samples were fixed for 24 hr in 4% neutral
buffered formalin, routinely processed, and embedded in
paraffin. Tissue sections 2- to 3-mm thick were stained with
hematoxylin and eosin or for reticulin fibers. The cutane-
ous, well-demarcated, invasively growing, unencapsulated
masses consisted of highly pleomorphic cells arranged in
interwoven bundles separated by a fine fibrovascular and
collagenous to myxoid stroma. There were no recognizable
classical structures such as whorls, palisading, or Antoni A
configurations of the neoplastic cells. The cells were partly
spindle shaped and partly plump fusiform to epitheloid
with an abundant eosinophilic homogeneous cytoplasm.
The nuclei were often centrally placed, round to oval, or
indented, and the chromatin was coarsely stippled. Most
cells contained a large, eosinophilic, prominent nucleolus
measuring up to 5 mm in diameter (Figs. 4, 5). In some
areas, several multinucleated giant cells were visible. The
mitotic rate was low, with 1–2 mitotic figures per 10 high-
power fields. Multiple small foci of necrosis were randomly
distributed within the larger tumor of the thorax. The
surface was extensively ulcerated and diffusely infiltrated
by neutrophils, macrophages, plasma cells, and lympho-
cytes. At the periphery of the neoplasia, no lymphocyte
aggregates could be found, as can be seen in feline vaccine–
induced sarcomas. With reticulin staining, the basement
membranes of the neoplastic cells showed positive reactiv-
ity. Additional 3-mm tissue sections for immunohistochem-
istry were mounted at 37uC on positively charged glass
slides,m deparaffinized in xylene, and rinsed in absolute
alcohol. The sections were incubated with a panel of
antibodies including pan-cytokeratin (Lu 5), neuron-
specific enolase (NSE), S-100 protein, glial fibrillary acidic
protein (GFAP), nerve growth factor receptor p75,
neurofilament 200 (NF 200) and neurofilament 70 (NF
70), vimentin, a-smooth muscle actin, factor VIII–related
antigen, melan A, cluster of differentiation (CD)3, CD79a,
lysozyme, and MAC 387 (see Table 1 for primary
antibodies and antigen retrieval).n Kupffer cells of the liver
were used as positive control for the MAC 387 antibody.
The tumor cells showed positive reactivity for S-100
protein, NSE (Fig. 6), GFAP (Fig. 7), and p 75 (Fig. 8)
but were negative for NF 200, NF 70, MAC 387, and melan
A. The histomorphological features and immunohisto-
chemistry results confirmed the diagnosis of malignant
peripheral nerve sheath tumor (PNST).
Three months after surgery, the tiger became anorectic
and apathic. Recurrent vomiting was observed, and no
feces were passed for 3 days. The tiger was anesthetized
using the previous protocol of medetomidine and ketamine.
The surgical site had healed with the exception of a small
superficial scar. No subcutaneous mass was palpable on
physical examination. Thoracic radiographs revealed mod-
erate pleural effusion, which made visualization of the heart
and diaphragm difficult. A large soft-tissue mass was seen
dorsocaudally in the thorax on the laterolateral view. The
left cranial lung lobe was only partially ventilated; the main
bronchus was pushed dorsally, and air bronchograms were
noted. The other lung lobes showed rounded contours and
were retracted. The ultrasonographic examination of the
thorax confirmed a moderate amount of anechoic free fluid
and multiple lobulated masses. Some masses were within
several lung lobes, whereas others were in the mediastinum.
On the basis of these findings, a tentative diagnosis of
metastases to the lung, mediastinum, and possibly the
pleura with secondary pleural effusion originating from the
subcutaneous tumor on the right thorax was made. Because
of the extensive masses, age of the animal, and poor
prognosis, the tiger was euthanized with pentobarbital
(350 mg/kg intravenously).o
The necropsy revealed multiple gray, firm, lobulated
nodules of variable diameter (up to 10 cm) in the lung and
mediastinum. There was also a severe hydrothorax with
approximately 3 liters of serosanguineous fluid resulting in
lung atelectasis. The pulmonary lymph nodes were normal
on gross inspection. Tissue samples were taken using the
same procedures as described earlier. Histologically, the
morphology of the neoplastic cells of the proliferations in
the mediastinum and lungs had a similar appearance to the
cells of the previously investigated masses. The metastases
had less extracellular matrix and were slightly less
differentiated. Rarely, the neoplasm showed differentiation
to a myxoid pattern with abundant extracellular matrix
consisting of mucopolysaccharide with embedded stellate
cells. Immunohistochemistry followed the previous proto-
col and demonstrated the same staining patterns as the
previously investigated masses. Based on the similar
histomorphological features and the same immunohisto-
chemical results, the diagnosis of malignant PNST was
confirmed, and the multiple nodules in the lung and in the
mediastinum were interpreted as metastases.
The present case apparently describes the first report of
PNST in a tiger. Limited published information is available
about PNSTs, despite sporadic reports from a wide range
of species including dogs, cows, horse, sheep, goats,
humans, rats, snakes, and cats, indicating they are
widespread in the animal kingdom. By far, most reports
are of tumors in cattle and dogs.3,6 In dogs, brachial plexus
and other spinal nerve root involvement are the most
commonly described locations.2,7 Metastases are rare but
may involve the lymph nodes and lung.1 PNSTs in the cat
are uncommon but may present as cutaneous tumors of
adult to aged cats.6,10,13–16 The true incidence of PNST in
large felids is unknown, with a single report of a
schwannoma in the larynx of a lion.12
The World Health Organization classification of tumors
of the nervous system and mesenchymal tumors of the skin
and soft tissues in domestic animals combines malignant
and benign forms of neurofibroma and schwannoma under
the title PNST.6 PNSTs arise from Schwann cells,
perineurial fibroblasts, or both.6 PNSTs may arise from
any anatomical site in the body, although skin and
subcutaneous sites are most common. Tumors occur as
slow-growing, nodular, lobulated, and poorly defined
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Figure 1. Siberian tiger (Panthera tigris altaica). Macroscopic picture of an ulcerating mass dorsally over the last rib, measuring
20 cm in diameter. The mass was well circumscribed, moveable, and spongy in consistency.
Figure 2. Siberian tiger (Panthera tigris altaica). Transverse computed tomographic image after an intravenous bolus injection of
iodinated contrast medium (left: dorsal, right: ventral, top: right). Both tumor masses are located in the subcutis of the right thorax, are
hypodense, and have fusiform dorsal extensions (arrows). Deeper layers of the thoracic wall are not involved.
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tumors, without histologic encapsulation. Clinically, how-
ever, the tumors may appear encapsulated, globoid,
lobulated, and of variable size and shape, depending on
the location. In general, tumors of peripheral nerves are
locally invasive and slow to metastasize.1
Histopathologic diagnosis is difficult because PNSTs
often lack classical morphological patterns and are thus
difficult to differentiate from other spindle-cell tumors such
as hemangiopericytomas, fibrosarcoma, anaplastic sarco-
mas with giant cells, melanoma, leiomyoma, or leiomyo-
sarcoma.5,7,10,14 Therefore, diagnosis requires further con-
firmation with immunohistochemical and/or ultrastructural
analyses.4,5,7,14 PNSTs may stain positively for S-100
protein, GFAP, laminin, NSE, nerve growth factor
receptor p75 (CD 271), and vimentin. However, up to
50% of malignant PNSTs do not express S-100 protein.11,14
In the current case, the histomorphological appearance
and the relatively rapid clinical course were initially
suggestive of an anaplastic sarcoma with giant cells.
However, the positive immunohistochemical staining for
neural and mesenchymal markers (S-100, GFAP, NSE,
p75, and vimentin) indicated a malignant PNST of the skin
with metastases to the mediastinum and lungs. A neurofi-
broma could be excluded by absence of staining of the
neoplastic cells for NF 70 and NF 200. The lack of labeling
for MAC 387 and lysozyme made a histiocytic lineage highly
unlikely. A mass with similar histological appearance and
immunohistochemical results has been described in a
domestic cat.15 Other tumors such as malignant lymphoma,
leiomyosarcoma, rhabdomyosarcoma, hemangiosarcoma,
malignant melanoma, or an epithelial malignant neoplasm
were excluded by a lack of staining for CD3, CD79a, desmin,
a-smooth muscle actin, factor VIII–related antigen, pan-
cytokeratin, and melan A. Because the definitive diagnosis of
malignant PNST requires more extensive laboratory testing,
it might be that the occurrence of malignant PNST is more
common in felids than currently thought.
Because of the low metastatic rate and poor chemother-
apy response,9 surgical excision and/or radiation therapy
are recommended as the preferred treatment for PNST in
domestic animals.1,2,7,9 Radiation therapy is the treatment
of choice if surgical excision lacks clean or tumor-free
margins. In the present case, CT images were particularly
useful to visualize tumor invasion of local tissue to allow
surgical excision with 2–3 cm of grossly normal tissue
around the mass and 1 additional tissue plane in depth,
including the panniculus muscle that was in contact with
the tumor. Complete resection of the primary tumor was
assumed, and postsurgical histological evaluation indicated
complete resection. Therefore, radiation treatment was not
considered because of the requirement for several sessions of
anesthesia. Further, local occurrence did not occur, support-
ing the speculation of complete resection of the tumor.
Nevertheless, the primary subcutaneous tumor evidently had
spread to the thoracic tissues 3 months later, contrary to
observations in domestic animals, where metastasis of
PNSTs was rarely detected and mostly limited to grade 3
tumors.8 Although local reccurrence, the most common
sequela of PNST, did not occur and lung radiographs did not
show any signs of tumor metastasis prior to surgery, it seems
that clinically undetectable micrometastases were already
present when surgery was attempted and were activated when
the primary tumor was removed.
As described in the domestic cat,5,6,13 cutaneous masses
were observed in the tiger in the present study but were
initially diagnosed as anaplastic sarcoma with giant cells.
Definitive diagnosis of PNST was made following immu-
nohistochemical evaluation of the tumor tissue. Theoreti-
cally, early diagnosis would permit a greater chance of
treatment success, but definitive diagnosis is possible only
with appropriate immunohistochemical staining.
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Figure 3. Siberian tiger (Panthera tigris altaica). Wound closure was performed with a mesh expansion technique to allow primary
healing after surgical removal of a peripheral nerve sheath tumor of the skin.
Figure 4. Siberian tiger (Panthera tigris altaica). Histological section from a malignant peripheral nerve sheath tumor of the skin
showing interwoven streams of spindloid and sheets of epitheloid tumor cells. Hematoxylin and eosin. Bar 5 100 mm.
Figure 5. Siberian tiger (Panthera tigris altaica). Histological section from a malignant peripheral nerve sheath tumor of the skin
showing spindle-shaped and epitheloid tumor cells. Hematoxylin and eosin. Bar 5 20 mm.
Figure 6. Siberian tiger (Panthera tigris altaica). Immunohistochemistry of a malignant peripheral nerve sheath tumor showing
neoplastic cells with strong red labeling for neuron-specific enolase. Bar 5 50 mm.
Figure 7. Siberian tiger (Panthera tigris altaica). Immunohistochemistry of a malignant peripheral nerve sheath tumor showing
neoplastic cells with strong red labeling for glial fibrillary acidic protein. Bar 5 50 mm.
Figure 8. Siberian tiger (Panthera tigris altaica). Immunohistochemistry of a malignant peripheral nerve sheath tumor showing
neoplastic cells with strong red labeling for nerve growth factor receptor p75. Bar 5 50 mm.
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Table 1. Characteristics of primary antibodies and antigen retrieval procedures performed for the definitive diagnosis of a
malignant peripheral nerve sheath tumor (primary cutaneous mass and lung metastases) in a Siberian tiger (Panthera tigris altaica).*
Primary antibody Pretreatment
Antibody
dilution Incubation time Detection method Source, catalog no.
Polyclonal antihuman pan
T-cell (CD3)
Pressure cooker,
20 min, 98uC,
basic buffer
DakoH S2367
1:250 1 hr at RT{ AEC, 10 min DakoH, A0452n
Monoclonal antihuman pan
B-cell (CD79a)
Pressure cooker,
20 min, 98uC,
basic buffer
DakoH S2367
1:300 1 hr at RT{ AEC, 10 min DakoH, M7051n
Monoclonal intermediate
filament protein desmin
Microwave, 4 min,
98uC, citrate
buffer
40 min at RT{ AEC, 10 min DakoH, M0724n
Polyclonal factor
VIII–related antigen
(Factor VIII)
Pressure cooker,
20 min, 98uC,
basic buffer
DakoH S2367
1 hr at RT{ AEC, 10 min DakoH, N1505n
Polyclonal GFAP Microwave, 3 min,
98uC, citrate
buffer
20 min at RT{ AEC, 10 min DakoH, H0083n
Polyclonal antihuman
lysozyme
Proteinase K,
DakoH, REAL
S2019, for 5 min
30 min at RT{ AEC, 10 min DakoH, M1515n
Monoclonal mouse
antihuman MAC 387
Water bath, 15 min,
98uC citrate buffer
1:400 AEC, 10 min DakoH, M0747n
Monoclonal antihuman
melan A
Microwave, 3 min,
98uC, citrate
buffer
1:10 1 hr at RT{ AEC, 10 min DakoH, M7196n
Monoclonal NSE Microwave, 3 min,
98uC, citrate
buffer
1:200 20 min at RT{ AEC, 10 min DakoH, M0873n
Polyclonal S-100 A and B Microwave, 3 min,
98uC, citrate
buffer
1 hr at RT{ AEC, 10 min DakoH, H0066n
Monoclonal smooth
muscle isoform of actin
(SM-actin)
Without 30 min at RT{ AEC, 10 min DakoH, H7114n
Monoclonal vimentin Proteinase K,
DakoH, REAL
S2019, for 10 min
30 min at RT{ DAB, 10 min DakoH, N1583n
Monoclonal antihuman
pan-cytokeratin
(cytokeratin 5, 6, 8, 17,
and ev. 19)
Proteinase K,
DakoH, REAL
S2019, for 5 min
1:50 30 min at RT{ DAB, 10 min DakoH, M0821n
Monoclonal antimouse
neurofilament 200
(NE14)
Hydrogen peroxide
for 60 min;
VentanaH
1:200 Overnight at RT{ DAB, 10 min Sigma, N5389
Monoclonal antimouse
neurofilament 70 (2F11)
Hydrogen peroxide
for 45 min;
VentanaH
1:50 30 min at RT{ DAB, 10 min DakoH, M0762
Monoclonal antimouse
CD271 (p75)
No treatment 1:20 Overnight at RT{ DAB, 10 min Mitenyi
* RT 5 room temperature; AEC 5 3-amino-9-ethylcarbazole; DAB 5 3,39-diaminobenzidine; GFAP 5 glial fibrillary acidic protein;
NSE 5 neuron-specific enolase.
{ Monoclonal and polyclonal antibodies were produced in mice and rabbits, respectively.
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m. Superfrost Color, Menzel, Braunschweig, Germany.
n. Dako Schweiz AG, Baar, Switzerland.
o. Vetanarcol,H Veterinaria AG, Zu¨rich, Switzerland.
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